1.
Advances in nanotechnology-enabled drug delivery for combining PARP inhibitors and immunotherapy in advanced ovarian cancer. Biomol Biomed [Internet]. 2024 Mar. 11 [cited 2024 May 20];24(2):230–237. Available from: https://bjbms.org/ojs/index.php/bjbms/article/view/9757